Riggs Josh
Insider CIK 1956391 · OCX Interim CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMDX Insight Molecular Diagnost | M Exercise deriv | 2026-03-26 | 2026-03-30 | 47,170 | — | $0 | 141,509 | SEC↗ |
| IMDX Insight Molecular Diagnost | F Tax w/h | 2026-03-26 | 2026-03-30 | 12,310 | $4.11 | $50.6K | 38,365 | SEC↗ |
| IMDX Insight Molecular Diagnost | M Exercise | 2026-03-26 | 2026-03-30 | 47,170 | — | $0 | 50,675 | SEC↗ |
| IMDX Insight Molecular Diagnost | A Award deriv | 2025-09-28 | 2025-09-30 | 400,000 | — | $0 | 400,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2025-03-26 | 2025-03-28 | 188,679 | — | $0 | 188,679 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2024-05-20 | 2024-05-22 | 90,000 | — | $0 | 90,000 | SEC↗ |
| OCX Oncocyte Corp | P Buy | 2024-04-11 | 2024-04-15 | 3,390 | $2.95 | $10.0K | 3,505 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2023-08-15 | 2023-08-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2023-06-09 | 2023-06-13 | 800,000 | — | $0 | 800,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2023-06-09 | 2023-06-13 | 350,000 | — | $0 | 350,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2023-02-24 | 2023-02-28 | 116,426 | — | $0 | 116,426 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2023-01-17 | 2023-01-19 | 257,485 | — | $0 | 257,485 | SEC↗ |